PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 118 filers reported holding PTC THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 1.38 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,770,000 | -30.4% | 162,274 | -10.6% | 0.00% | -33.3% |
| Q3 2016 | $2,542,000 | +97.5% | 181,471 | -1.0% | 0.00% | +50.0% |
| Q2 2016 | $1,287,000 | +27.3% | 183,317 | +16.8% | 0.00% | +100.0% |
| Q1 2016 | $1,011,000 | -77.4% | 156,956 | +13.5% | 0.00% | -83.3% |
| Q4 2015 | $4,479,000 | +22.7% | 138,246 | +1.1% | 0.01% | +20.0% |
| Q3 2015 | $3,650,000 | -45.5% | 136,688 | -1.8% | 0.01% | -37.5% |
| Q2 2015 | $6,697,000 | +14.7% | 139,146 | +45.1% | 0.01% | 0.0% |
| Q1 2015 | $5,837,000 | +24.8% | 95,918 | +6.2% | 0.01% | +33.3% |
| Q4 2014 | $4,676,000 | +62.2% | 90,328 | +37.9% | 0.01% | +50.0% |
| Q3 2014 | $2,882,000 | +69.8% | 65,486 | +0.9% | 0.00% | +100.0% |
| Q2 2014 | $1,697,000 | +99.9% | 64,901 | +99.9% | 0.00% | +100.0% |
| Q1 2014 | $849,000 | +83.0% | 32,462 | +18.8% | 0.00% | 0.0% |
| Q4 2013 | $464,000 | -17.9% | 27,331 | +3.8% | 0.00% | 0.0% |
| Q3 2013 | $565,000 | – | 26,325 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 110,794 | $3,802,000 | 10.50% |
| Boxer Capital, LLC | 2,155,000 | $73,960,000 | 9.14% |
| RTW INVESTMENTS, LP | 1,922,346 | $65,975,000 | 6.14% |
| GREAT POINT PARTNERS LLC | 1,225,000 | $42,042,000 | 5.31% |
| Opaleye Management Inc. | 190,000 | $6,520,000 | 2.43% |
| SCOPIA CAPITAL MANAGEMENT LP | 1,626,965 | $55,837,000 | 1.89% |
| SPHERA FUNDS MANAGEMENT LTD. | 345,500 | $11,858,000 | 1.34% |
| SECTORAL ASSET MANAGEMENT INC | 233,536 | $8,015,000 | 1.09% |
| Elk Creek Partners, LLC | 377,674 | $12,962,000 | 1.08% |
| Orbimed Advisors | 1,519,700 | $52,156,000 | 0.96% |